Can sugar and fat influence immune cell responses?
LA JOLLA, CA—A population of unconventional white blood cells has recently captured the attention of immunologists and clinicians alike. Unlike
Even as SARS-CoV-2 mutates, some human antibodies fight back
LA JOLLA, CA—An anonymous San Diego resident has become a fascinating example of how the human immune system fights SARS-CoV-2.
We’ve learned a lot from lymphocytic choriomeningitis virus—now the time has come to fight it
Key Findings: There are no vaccines or therapies available for lymphocytic choriomeningitis virus (LCMV) infection. This pathogen spreads easily and
Lasting relief may be on the horizon for patients with atopic dermatitis
LJI research collaboration with Kyowa Kirin Co., Ltd., points to a novel approach to treat the most common form of eczema
LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved
Durable SARS-CoV-2 antibodies bind to two viral targets at once
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
LJI scientists solve the mystery of why OGT enzyme is critical for cell survival
LA JOLLA, CA — Researchers at La Jolla Institute for Immunology (LJI) have at last uncovered how an enzyme called
LJI researchers find missing piece of the asthma puzzle
New study reveals how the inflammatory "LIGHT" protein leads to airway remodeling and long-term breathing issues
On the trail of missing genes and cancer clues
LJI scientists connect TET loss of function to missing genes in embryonic stem cells
New Lassa fever therapy may be on the horizon
Three rare antibodies, combined in a "cocktail," are effective in fighting Lassa virus
Immunologic defect may leave some vulnerable to rare bacterial infection
LA JOLLA, CA—Everyone breathes in Mycobacterium avium complex (MAC) bacteria from time to time, but most people don’t get sick.
The longer the bootcamp, the better the antibodies
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) have discovered how the immune system can transform into an